| FREQUENCY OF POSITIVE ANTIBODY INDECES (AIs) FOR MEASLES, RUBELLA, ZOSTER | ||||||
| Applied threshold defining a positive AI | ≥1.5 | >2.0 | ≥1.5 | >2.0 | ≥1.5 | >2.0 |
| Positive AIs (Measles), n (%) | 4 (10) | 2 (5) | 40 (58.8) | 31 (45.6) | p < 0.0001 | p < 0.0001 |
| Positive AIs (Rubella), n (%) | 4 (10) | 2 (5) | 33 (48.5) | 27 (39.7) | p < 0.0001 | p < 0.0001 |
| Positive AIs (Zoster), n (%) | 5 (12.5) | 3 (7.5) | 30 (44.1) | 21 (30.9) | p = 0.0006 | p = 0.0043 |
| FREQUENCY OF PATIENTS WITH 0, 1, 2, 3 POSITIVE ANTIBODY INDECES (AI) | ||||||
| Applied threshold defining a positive AI | ≥1.5 | >2.0 | ≥1.5 | >2.0 | ≥1.5 | >2.0 |
| 0 positive AI, n (%) | 32 (80) | 35 (88) | 13 (19.1) | 21 (30.9) | p < 0.0001 | p < 0.0001 |
| 1 positive AI, n (%) | 3 (7.5) | 3 (7.5) | 18 (26.5) | 22 (32.4) | p = 0.0221 | p = 0.0039 |
| 2 positive AIs, n (%) | 3 (7.5) | 1 (2.5) | 19 (27.9) | 16 (23.5) | p = 0.0128 | p = 0.0048 |
| 3 positive AIs, n (%) | 2 (5) | 1 (2.5) | 18 (26.5) | 9 (13.2) | p = 0.0049 | n.s. |
AI, antibody index; ANA, antinuclear antibody; ANCA, anti-neutrophil cytoplasmic antibodies; APA, antiphospholipid antibodies; dsDNA, double stranded DNA; IIF, indirect immunofluorescence; M, measles; MS, multiple sclerosis; n, number of patients; n.s., not significant; RDwCNS, rheumatic diseases with involvement of the central nervous system; R, rubella; SD, standard deviation; Z, varicella zoster. The bold values are the applied thresholds (>1.5 or >2.0) defining a positive AI for the calculation of the MRZR.